Common Brain Network Identified for Multiple Psychiatric Disorders May...
Psychiatric disorders are typically studied individually, even though up to half of the patients meet the criteria for multiple disorders. Genomic and epidemiologic evidence suggests different...
View ArticlePhysical, Cognitive Decline Accelerated in People With Late-Life Depression
Emerging evidence suggests cellular senescence is a hallmark of aging. Cells lose their proliferative capacity, become resistant to apoptosis, and develop a senescence-associated secretory phenotype...
View ArticleKetamine Is Noninferior to ECT for Nonpsychotic Treatment-resistant Major...
Ketamine, administered intravenously at a subanesthetic dose, is being used increasingly often for patients with treatment-resistant major depressive disorder. It can lead to transient changes in...
View ArticleNeuroimaging Abnormalities Across Substance Use Disorders Map to a Common...
In 2023, a Brigham and Women’s Hospital team published evidence in Nature Human Behaviour that six psychiatric disorders map to a common brain network. The results suggested neuromodulation targets for...
View ArticleEffects of Modafinil on Cognition and Sleep Quality in Affectively Stable...
Most patients with bipolar disorder experience circadian dysfunction and deficits in attention, verbal memory, and executive functioning, even during periods of euthymia. Katherine E. Burdick, PhD,...
View ArticleReview: Mental Health Over the Menopause Transition
A 1959 paper in the Journal of the American Medical Association described menopause as a “rather unpleasant and possibly dangerous” period of life and presented what became the first widely used...
View ArticleTreatment of Depression/Anxiety in Osteoarthritis Linked to Better...
Depression and anxiety are common comorbidities of osteoarthritis (OA) of the hip or knee, yet surprisingly, little is known about how pharmacologic treatment for these conditions affects...
View ArticleSocial Technology and Aging: A Q&A with Dr. Hong-Tu Chen
As the global population ages, the integration of technology into eldercare has become a critical area of focus. While gerontechnology has advanced the intersection of aging studies and technological...
View ArticlePeer Recovery Coaches Generally Support, but Have Concerns About Therapeutic...
Evidence is accumulating that psychedelics, including LSD, psilocybin (“magic mushrooms”), and ketamine, may have a role in treating substance use disorders (SUD). However, until recently, no research...
View ArticleThe Efficacy of GLP-1 Agonists in Treating Substance Use Disorder
Glucagon-like peptide-1 (GLP-1) agonists are now recognized as having the potential to treat conditions besides metabolic disease, perhaps including substance use disorder (SUDs). GLP-1 agonists are...
View Article